Ocean Biomedical (OCEA) Stock Price, News & Analysis

Company Overview

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Key Stats

• Today's Range: $0.0004 to $0.0014
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0096
• Volume: 4,832 shs
• Average Volume: 68,786 shs
• Market Capitalization: $232.42 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ocean Biomedical Stock Analysis - MarketRank™

Ocean Biomedical scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ocean Biomedical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ocean Biomedical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ocean Biomedical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.71% of the float of Ocean Biomedical has been sold short.

Short Interest Ratio / Days to Cover

Ocean Biomedical has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ocean Biomedical does not currently pay a dividend.

Dividend Growth

Ocean Biomedical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Ocean Biomedical this week, compared to 0 articles on an average week.

Search Interest

2 people have searched for OCEA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.95% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

24.55% of the stock of Ocean Biomedical is held by institutions.

Company Calendar

• Last Earnings: 4/08/2025
• Today: 8/30/2026
• Next Earnings (Estimated): 9/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OCEA
• CIK: 1836612
• Web: N/A
• Phone: 646-908-2658
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$114.47 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -931.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.62) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 166,011,000
• Free Float: 9,240,000
• Market Cap: $232.42 thousand
• Optionable: No Data
• Beta: 1.63